Amundi Index Solutions News - C003

Phreesia Sets Release Date for Fiscal First Quarter 2023 Results

Phreesia, Inc. (NYSE: PHR) (“Phreesia”) today announced that it will release its fiscal first quarter 2023 financial results after the close of...

Phreesia’s Danielle Lynch Named One of MM+M’s ‘Women to Watch’ for 2022

Phreesia is pleased to announce that the healthcare marketing industry trade MM+M has named Danielle Lynch, Vice President, Client Experience, to...

Phreesia Announces Fiscal Year Ended January 31, 2022 Results

Phreesia, Inc. (NYSE: PHR) (“Phreesia” or the "Company") announced financial results today for the fiscal fourth quarter and fiscal year ended...

Phreesia Sets Release Date for Fiscal Fourth Quarter 2022 Results

Phreesia, Inc. (NYSE: PHR) (“Phreesia”) will hold a conference call on Wednesday, March 30, 2022, at 5:00 p.m. Eastern Time to discuss the...

Phreesia Named 2022 Best in KLAS for Patient Intake Management for a Fourth Year

Phreesia (NYSE: PHR) is pleased to announce it has been named 2022 Best in KLAS for Patient Intake Management by the research and insights firm...

Phreesia’s Amy VanDuyn Named a Top 10 HR Professional at the OnCon Icon Awards

Phreesia is proud to announce that Amy VanDuyn, the company’s SVP of Human Resources, has been named a Top 10 HR Professional at the 2022 OnCon...

Phreesia Included in the 2022 Bloomberg Gender-Equality Index for the Second Year

Phreesia is pleased to announce that it is one of 418 companies across 45 countries and regions to join the 2022 Bloomberg Gender-Equality Index...

Phreesia Joins Greenfield, MEDITECH’s Application Developer Environment

Phreesia is pleased to announce that it is now a part of MEDITECH Greenfield, a testing ground for apps that can integrate with MEDITECH Expanse...

Phreesia Life Sciences’ PatientInsights Named one of PM360’s 2021 Most Innovative Services

Phreesia is pleased to announce that the healthcare marketing industry trade publication PM360 has named PatientInsights, Phreesia Life Sciences’...

Phreesia Life Sciences Named one of MM+M’s “Best Places to Work 2021”

Phreesia is pleased to announce that the healthcare marketing industry trade publication Medical Marketing and Media (MM+M) has named Phreesia...

Phreesia Announces Acquisition of Insignia Health, LLC, Redoubling Its Commitment to Improve Patients’ Experience and Outcomes

Phreesia is excited to announce it has acquired Insignia Health, LLC, a founder-led and mission-oriented company dedicated to improving health...

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Amundi Index Solutions (C003)

Empower your portfolio: Real-time discussions and actionable trading ideas.

C003 News

Phreesia Sets Release Date for Fiscal First Quarter 2023 Results

Phreesia’s Danielle Lynch Named One of MM+M’s ‘Women to Watch’ for 2022

Phreesia Announces Fiscal Year Ended January 31, 2022 Results

Phreesia Sets Release Date for Fiscal Fourth Quarter 2022 Results

Phreesia Named 2022 Best in KLAS for Patient Intake Management for a Fourth Year

Phreesia’s Amy VanDuyn Named a Top 10 HR Professional at the OnCon Icon Awards

Phreesia Included in the 2022 Bloomberg Gender-Equality Index for the Second Year

Phreesia Joins Greenfield, MEDITECH’s Application Developer Environment

Phreesia Life Sciences’ PatientInsights Named one of PM360’s 2021 Most Innovative Services

Phreesia Life Sciences Named one of MM+M’s “Best Places to Work 2021”

Phreesia Announces Acquisition of Insignia Health, LLC, Redoubling Its Commitment to Improve Patients’ Experience and Outcomes

Phreesia Announces Fiscal Third Quarter 2022 Results

Phreesia Sets Release Date for Fiscal Third Quarter 2022 Results

Phreesia’s Allison Hoffman Named a Top Woman Leader in SaaS

Phreesia Names Ramin Sayar to its Board of Directors

C003 Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Amundi Index Solutions (C003) News

Amundi Index Solutions (C003)

Empower your portfolio: Real-time discussions and actionable trading ideas.

C003 News

Phreesia Sets Release Date for Fiscal First Quarter 2023 Results

Phreesia’s Danielle Lynch Named One of MM+M’s ‘Women to Watch’ for 2022

Phreesia Announces Fiscal Year Ended January 31, 2022 Results

Phreesia Sets Release Date for Fiscal Fourth Quarter 2022 Results

Phreesia Named 2022 Best in KLAS for Patient Intake Management for a Fourth Year

Phreesia’s Amy VanDuyn Named a Top 10 HR Professional at the OnCon Icon Awards

Phreesia Included in the 2022 Bloomberg Gender-Equality Index for the Second Year

Phreesia Joins Greenfield, MEDITECH’s Application Developer Environment

Phreesia Life Sciences’ PatientInsights Named one of PM360’s 2021 Most Innovative Services

Phreesia Life Sciences Named one of MM+M’s “Best Places to Work 2021”

Phreesia Announces Acquisition of Insignia Health, LLC, Redoubling Its Commitment to Improve Patients’ Experience and Outcomes

Phreesia Announces Fiscal Third Quarter 2022 Results

Phreesia Sets Release Date for Fiscal Third Quarter 2022 Results

Phreesia’s Allison Hoffman Named a Top Woman Leader in SaaS

Phreesia Names Ramin Sayar to its Board of Directors

C003 Discussion

Your Recent History